These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35983519)

  • 1. Implementation of an outbreak response vaccination campaign with typhoid conjugate vaccine - Harare, Zimbabwe, 2019.
    Poncin M; Marembo J; Chitando P; Sreenivasan N; Makwara I; Machekanyanga Z; Nyabyenda W; Mukeredzi I; Munyanyi M; Hidle A; Chingwena F; Chigwena C; Atuhebwe P; Matzger H; Chigerwe R; Shaum A; Date K; Garone D; Chonzi P; Barak J; Phiri I; Rupfutse M; Masunda K; Gasasira A; Manangazira P
    Vaccine X; 2022 Dec; 12():100201. PubMed ID: 35983519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe.
    Shaum A; Mujuru HA; Takamiya M; Ticklay I; Nathoo K; Sreenivasan N; Nyambayo P; Chitando P; Marembo J; Koline Chigodo C; Mukaratirwa A; Jacha V; Gidudu JF; Rupfutse M; Kumar Jain S; Manangazira P; Bennett SD
    Vaccine; 2022 Jun; 40(26):3573-3580. PubMed ID: 35568590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Date K; Shimpi R; Luby S; N R; Haldar P; Katkar A; Wannemuehler K; Mogasale V; Pallas S; Song D; Kunwar A; Loharikar A; Yewale V; Ahmed D; Horng L; Wilhelm E; Bahl S; Harvey P; Dutta S; Bhatnagar P
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S172-S178. PubMed ID: 32725235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to Improve Coverage of Typhoid Conjugate Vaccine (TCV) Immunization Campaign in Karachi, Pakistan.
    Qamar FN; Batool R; Qureshi S; Ali M; Sadaf T; Mehmood J; Iqbal K; Sultan A; Duff N; Yousafzai MT
    Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33228111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.
    Lightowler MS; Manangazira P; Nackers F; Van Herp M; Phiri I; Kuwenyi K; Panunzi I; Garone D; Marume F; Tarupiwa A; Ferreras E; Duri C; Luquero FJ
    Vaccine; 2022 Jul; 40(31):4199-4210. PubMed ID: 35690501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a comprehensive typhoid conjugate vaccine campaign on antimicrobial prescribing in children in Harare, Zimbabwe: a mixed methods study.
    Olaru ID; Chingono RMS; Bottomley C; Kandiye FR; Mhino F; Nyamayaro CA; Manyau S; Vere M; Chitando P; Chonzi P; Darton TC; Dixon J; Kranzer K
    Lancet Glob Health; 2023 Sep; 11(9):e1422-e1431. PubMed ID: 37591588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study.
    Phillips MT; Antillon M; Bilcke J; Bar-Zeev N; Limani F; Debellut F; Pecenka C; Neuzil KM; Gordon MA; Thindwa D; Paltiel AD; Yaesoubi R; Pitzer VE
    BMC Infect Dis; 2023 Mar; 23(1):143. PubMed ID: 36890448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad, Pakistan.
    Qamar FN; Yousafzai MT; Khaliq A; Karim S; Memon H; Junejo A; Baig I; Rahman N; Bhurgry S; Afroz H; Sami U
    Vaccine; 2020 Apr; 38(19):3518-3523. PubMed ID: 32201138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study.
    Yousafzai MT; Karim S; Qureshi S; Kazi M; Memon H; Junejo A; Khawaja Z; Ur Rehman N; Ansari MS; Ali R; Ujjan IU; Lohana HM; Memon NM; Hussain M; Nigar R; Bar-Zeev N; Qamar FN
    Lancet Glob Health; 2021 Aug; 9(8):e1154-e1162. PubMed ID: 34297962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Vaccine Safety After the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Longley AT; Date K; Luby SP; Bhatnagar P; Bentsi-Enchill AD; Goyal V; Shimpi R; Katkar A; Yewale V; Jayaprasad N; Horng L; Kunwar A; Harvey P; Haldar P; Dutta S; Gidudu JF
    Clin Infect Dis; 2021 Aug; 73(4):e927-e933. PubMed ID: 33502453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parental acceptance of typhoid conjugate vaccine for children aged 6 months to 15 years in an outbreak setting of Lyari Town Karachi, Pakistan.
    Batool R; Yousafzai MT; Qureshi S; Muhammad S; Qazi I; Sadaf T; Ashorn P; Qamar FN
    Vaccine; 2023 Aug; 41(37):5376-5382. PubMed ID: 37463829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India.
    Song D; Pallas SW; Shimpi R; Ramaswamy N; Haldar P; Harvey P; Bhatnagar P; Katkar A; Jayaprasad N; Kunwar A; Bahl S; Morgan W; Hutubessy R; Date K; Mogasale V
    PLOS Glob Public Health; 2023; 3(1):e0001396. PubMed ID: 36962873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.
    Poncin M; Zulu G; Voute C; Ferreras E; Muleya CM; Malama K; Pezzoli L; Mufunda J; Robert H; Uzzeni F; Luquero FJ; Chizema E; Ciglenecki I
    Bull World Health Organ; 2018 Feb; 96(2):86-93. PubMed ID: 29403111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
    Kumar Rai G; Saluja T; Chaudhary S; Tamrakar D; Kanodia P; Giri BR; Shrestha R; Uranw S; Kim DR; Yang JS; Park IY; Kyung SE; Vemula S; Reddy E J; Kim B; Gupta BP; Jo SK; Ryu JH; Park HK; Shin JH; Lee Y; Kim H; Kim JH; Mojares ZR; Wartel TA; Sahastrabuddhe S
    Lancet Infect Dis; 2022 Apr; 22(4):529-540. PubMed ID: 34942090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework.
    Debellut F; Mkisi R; Masoo V; Chisema M; Mwagomba D; Mtenje M; Limani F; Mategula D; Zimba B; Pecenka C
    Vaccine; 2022 Mar; 40(12):1741-1746. PubMed ID: 35153097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh.
    Weyant C; Hooda Y; Munira SJ; Lo NC; Ryckman T; Tanmoy AM; Kanon N; Seidman JC; Garrett D; Saha SK; Goldhaber-Fiebert JD; Saha S; Andrews JR
    Vaccine; 2024 Apr; 42(11):2867-2876. PubMed ID: 38531727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
    Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
    Meiring JE; Laurens MB; Patel P; Patel P; Misiri T; Simiyu K; Mwakiseghile F; Tracy JK; Masesa C; Liang Y; Henrion M; Rotrosen E; Gmeiner M; Heyderman R; Kotloff K; Gordon MA; Neuzil KM
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S50-S58. PubMed ID: 30845320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
    da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
    Sante; 2003; 13(4):215-23. PubMed ID: 15047438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
    Mahomva AI; Moyo IM; Mbengeranwa LO
    Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.